What is it?
Our medically supervised weight management programme uses the latest GLP-1 receptor agonist medications (Ozempic/semaglutide and Mounjaro/tirzepatide) to support significant, sustainable weight loss. Administered under physician supervision with ongoing monitoring and lifestyle support.
How does it work?
Following a thorough medical assessment, our physician prescribes the appropriate medication and dosage. Weekly subcutaneous injections reduce appetite, improve insulin sensitivity and promote weight loss. The programme includes regular follow-up appointments and nutritional guidance.
Key benefits
- Clinically proven weight loss of 10–20%+ body weight
- Reduces appetite and food cravings
- Improves blood sugar control
- Administered under physician supervision
- Weekly injection with minimal discomfort
- Can be combined with body contouring treatments
- Comprehensive monitoring and support
Who is it for?
- Adults with a BMI over 27 seeking medical weight loss support
- Those who have not achieved results with diet and exercise alone
- Patients with type 2 diabetes or pre-diabetes
- Anyone seeking a medically supervised weight management programme
Frequently asked questions
How quickly do results appear?
Most patients begin losing weight within the first 2–4 weeks.
Are these medications safe?
Both Ozempic and Mounjaro are approved medications with established safety profiles when prescribed appropriately.
What is the difference between Ozempic and Mounjaro?
Mounjaro (tirzepatide) acts on two receptors vs Ozempic's one, typically delivering greater weight loss.
Is long-term use required?
Duration varies. Our physician will guide you based on your goals and response.